These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Current clinical practice in atopic dermatitis. Odedra KM Nurs Stand; 2014 Aug; 28(49):45-51. PubMed ID: 25095959 [TBL] [Abstract][Full Text] [Related]
6. Emerging therapies for atopic dermatitis: The prostaglandin/leukotriene pathway. Yanes DA; Mosser-Goldfarb JL J Am Acad Dermatol; 2018 Mar; 78(3 Suppl 1):S71-S75. PubMed ID: 29248523 [TBL] [Abstract][Full Text] [Related]
7. Successful treatment of severe atopic dermatitis with cysteinyl leukotriene receptor antagonist montelukast. Angelova-Fischer I; Tsankov N Acta Dermatovenerol Alp Pannonica Adriat; 2005 Sep; 14(3):115-9. PubMed ID: 16200338 [TBL] [Abstract][Full Text] [Related]
8. Atopic Dermatitis: The New Therapeutic Revolution in Dermatology. Torres T Acta Med Port; 2017 Oct; 30(10):669-670. PubMed ID: 29268058 [No Abstract] [Full Text] [Related]
9. [Transfer factor as specific immunomodulator in the treatment of moderate-severe atopic dermatitis]. Flores Sandoval G; Gómez Vera J; Orea Solano M; López Tiro J; Serrano E; Rodríguez A; Rodríguez A; Estrada Parra S; Jiménez Saab N Rev Alerg Mex; 2005; 52(6):215-20. PubMed ID: 16568705 [TBL] [Abstract][Full Text] [Related]
10. [Dynamics of interferon status in patients with atopic dermatitis during standard therapy combined with cycloferon]. Gevorkian OV; Smirnova TD; Manakhova LS; Ospel'nikova TP Klin Med (Mosk); 2011; 89(4):54-5. PubMed ID: 21932566 [TBL] [Abstract][Full Text] [Related]
11. Failure of omalizumab for treatment of severe adult atopic dermatitis. Krathen RA; Hsu S J Am Acad Dermatol; 2005 Aug; 53(2):338-40. PubMed ID: 16021135 [TBL] [Abstract][Full Text] [Related]
12. Cyclosporin maintenance therapy for severe atopic dermatitis. Korstanje MJ; van de Staak WJ Acta Derm Venereol; 1991; 71(4):356-7. PubMed ID: 1681659 [TBL] [Abstract][Full Text] [Related]
13. Cyclosporine A in atopic dermatitis. Gaig P; Alijotas J; López A; Valencia M; Cisteró A Allergol Immunopathol (Madr); 1993; 21(5):169-72. PubMed ID: 8160560 [TBL] [Abstract][Full Text] [Related]
16. Non-corticosteroid adherence and itch severity influence perception of itch in atopic dermatitis. Takeuchi S; Oba J; Esaki H; Furue M J Dermatol; 2018 Feb; 45(2):158-164. PubMed ID: 29168215 [TBL] [Abstract][Full Text] [Related]
17. [Long term management of childhood atopic dermatitis with calcineurin inhibitors]. Thaçi D Hautarzt; 2003 May; 54(5):418-23. PubMed ID: 12719861 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of pimecrolimus 1% cream in the long term management of atopic hand dermatitis. A double-blind RCT. Bauer A; Lange N; Matterne U; Meurer M; Braeutigam M; Diepgen TL J Dtsch Dermatol Ges; 2012 Jun; 10(6):426-33. PubMed ID: 22112014 [TBL] [Abstract][Full Text] [Related]
19. Topical pimecrolimus: a review of its clinical potential in the management of atopic dermatitis. Wellington K; Jarvis B Drugs; 2002; 62(5):817-40. PubMed ID: 11929333 [TBL] [Abstract][Full Text] [Related]